Abstract:Lactate is the primary tumor immunosuppressive factor limiting the effectiveness of tumor treatment. The authors develop a secure biocatalytic immunoenhancement strategy to boost antitumor immunity by consuming intratumoral lactate and inducing metabolic reprogramming using a nanoreactor. Through the design of this delicate catalytic immunoenhancement strategy, nanoreactors with lactate as a target may open a promising and secure avenue for tumor therapy. Lactate, a characteristic metabolite of the tumor microenvironment (TME), drives immunosuppression and promotes tumor progression. Material‐engineered strategies for intratumoral lactate modulations demonstrate their promise for tumor immunotherapy. However, understanding of the inherent interconnections of material‐enabled lactate regulation, metabolism, and immunity in the TME is scarce. To address this issue, urchin‐like catalysts of the encapsulated Gd‐doped CeO2, syrosingopine, and lactate oxidase are used in ZIF‐8 (USL, where U, S, and L represent the urchin‐like Gd‐doped CeO2@ZIF‐8, syrosingopine, and lactate oxidase, respectively) and orthotopic tumor models. The instructive relationships of intratumoral lactate depletion, metabolic reprogramming, and immune activation for catalytic immunotherapy of tumors is illustrated. The catalysts efficiently oxidize intratumoral lactate and significantly promote tumor cell apoptosis by in situ‐generated ·OH, thereby reducing glucose supply and inducing mitochondrial damage via lactate depletion, thus reprogramming glycometabolism. Subsequently, such catalytic metabolic reprogramming evokes both local and systemic antitumor immunity by activating M1‐polarizaed macrophages and CD8+ T cells, leading to potent antitumor immunity. This study provides valuable mechanistic insights into material‐interfered tumor therapy through intratumoral lactate depletion and consequential connection with metabolic reprogramming and immunity remodeling, which is thought to enhance the efficacy of immunotherapy.

Nanosystem-mediated Lactate Modulation in the Tumor Micro Environment for Enhanced Cancer Therapy

Engineering lactate-modulating nanomedicines for cancer therapy

Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy

Lactate in the tumor microenvironment: A rising star for targeted tumor therapy

Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies

Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target

Catalytic Modulation of the Tumor Microenvironment Using Cascade Enzymes for Synergistic Boron Neutron Capture Therapy in the Treatment of Gliomas

Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy

Intervention on lactate in cancer: A promising approach for the development of cancer therapeutics

Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism

Lactate in the tumour microenvironment: From immune modulation to therapy

Metabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy

The emerging role of lactate in tumor microenvironment and its clinical relevance

Recent advances in nanomedicine for metabolism-targeted cancer therapy

Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity

Tumor Microenvironment-Modulated Multiple Nanotherapeutic System for Potent Cancer Immunotherapy and Metastasis Inhibition

Targeting lactate-related cell cycle activities for cancer therapy

Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment

The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment

Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer